We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > seizure

News List

Generic version of seizure drug Sabril gets FDA approval europeanpharmaceuticalreview
January 21, 2019
A generic version of the seizure drug Sabril (vigabatrin) has been approved by the FDA…
FDA Acts to Remove Unproven, Potentially Harmful Treatment Used In 'Stem Cell' Centers americanpharmaceuticalreview
August 30, 2017
The U.S. Food and Drug Administration (FDA) took decisive action to prevent the use of a potentially dangerous and unproven treatment belonging to StemImmune in San Diego, California, and administered to patients at the California Stem Cell Treatment Cent
Zydus Pharma recalls 3.31 lakh bottles of seizure drug in US expressbpd
August 11, 2017
The tablets were manufactured by Ahmedabad-based Cadila Healthcare and are being recalled on account of failed dissolution specifications

Previous page 1 2 Next page